We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

UK Accuses Drugmakers Of Anti-Competitive Agreements

Law360, London (February 28, 2019, 10:10 PM GMT) -- Actavis illegally made monthly payments to Waymade to not enter the market for a generic hormone-replacement treatment and then charged the country’s national health care provider excessive prices for the drug,...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.